KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Capital Expenditures (2016 - 2025)

Jazz Pharmaceuticals has reported Capital Expenditures over the past 16 years, most recently at $816.0 million for Q4 2025.

  • Quarterly Capital Expenditures rose 3392.7% to $816.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $858.1 million through Dec 2025, changed N/A year-over-year, with the annual reading at $858.1 million for FY2025, N/A changed from the prior year.
  • Capital Expenditures was $816.0 million for Q4 2025 at Jazz Pharmaceuticals, up from -$816.0 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $844.2 million in Q2 2025 and troughed at -$816.0 million in Q3 2025.
  • The 5-year median for Capital Expenditures is $7.8 million (2021), against an average of $46.9 million.
  • Peak annual rise in Capital Expenditures hit 11804.84% in 2025, while the deepest fall reached 7664.24% in 2025.
  • Tracing JAZZ's Capital Expenditures over 5 years: stood at $10.0 million in 2021, then dropped by 5.91% to $9.4 million in 2022, then increased by 7.72% to $10.1 million in 2023, then crashed by 345.33% to -$24.8 million in 2024, then soared by 3392.7% to $816.0 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $816.0 million, -$816.0 million, and $844.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.